Determinants of optimal mastectomy skin flap thickness

British Journal of Surgery

Volumn 101, Issue 8, 2014, Pages 899-911

  Robertson, S A ^a   Rusby, J E ^b   Cutress, R I ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; FEMALE; HUMAN; MASTECTOMY; METHODOLOGY; MINIMAL RESIDUAL DISEASE; PATHOLOGY; REOPERATION; REVIEW; STATISTICS; SURGICAL FLAPS; TUMOR RECURRENCE;

BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; REOPERATION; SURGICAL FLAPS;

EID: 84902291491     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9470     Document Type: Review

References (85)

1. Lawrence G, Kearins O, Lagord C, Cheung S, Sidhu J, Sagar C,. The Second All Breast Cancer Report. http://www.wmciu.nhs.uk/documents/SecondABCR.pdf [accessed 1 March 2013].
2. Katipamula R, Degnim AC, Hoskin T, Boughey JC, Loprinzi C, Grant CS, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 2009; 27: 4082-4088.
3. Morrow M, Harris JR,. More mastectomies: is this what patients really want? J Clin Oncol 2009; 27: 4038-4040.
4. Macmillan RD,. Techniques of mastectomy: tips and pitfalls. In Breast Surgery: a Companion to Specialist Surgical Practice (4th edn), Dixon JM, (ed.). Saunders Elsevier: Edinburgh, 2009; 67-76.
5. Coombs NJ, Royle GT,. How to draw the skin ellipse for a mastectomy. Ann R Coll Surg Engl 1999; 81: 248-250.
6. Rainsbury RM,. Skin-sparing mastectomy. Br J Surg 2006; 93: 276-281.
7. Sainsbury R,. Breast. In General Surgical Operations (5th edn), Kirk RM, (ed.). Elsevier: London, 2006; 378-380.
8. Agrawal A, Sibbering DM, Courtney CA,. Skin sparing mastectomy and immediate breast reconstruction: a review. Eur J Surg Oncol 2013; 39: 320-328.
9. Freeman BS,. Subcutaneous mastectomy for benign breast lesions with immediate or delayed prosthetic replacement. Plast Reconstr Surg Transplant Bull 1962; 30: 676-682.
10. Toth BA, Lappert P,. Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning. Plast Reconstr Surg 1991; 87: 1048-1053.
11. Lanitis S, Tekkis PP, Sgourakis G, Dimopoulos N, Al Mufti R, Hadjiminas DJ,. Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies. Ann Surg 2010; 251: 632-639.
12. Kroll SS, Khoo A, Singletary SE, Ames FC, Wang BG, Reece GP, et al. Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up. Plast Reconstr Surg 1999; 104: 421-425.
13. Gerber B, Krause A, Reimer T, Muller H, Kuchenmeister I, Makovitzky J, et al. Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg 2003; 238: 120-127.
14. Jeevan R, Cromwell D, Browne J, Van Der Meulen J, Pereira J, Caddy C, et al. National Mastectomy and Breast Reconstruction Audit 2010 (Third Annual Report). http://www.rcseng.ac.uk/surgeons/research/surgical-research/docs/ national-mastectomy-and-breast-reconstruction-audit-third-report-2010 [accessed 1 March 2013].
15. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al.; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 17: 2087-2106.
16. Lockwood TE,. Superficial fascial system (SFS) of the trunk and extremities: a new concept. Plast Reconstr Surg 1991; 87: 1009-1018.
17. Abu-Hijleh MF, Roshier AL, Al-Shboul Q, Dharap AS, Harris PF,. The membranous layer of superficial fascia: evidence for its widespread distribution in the body. Surgical and radiologic anatomy. Surg Radiol Anat 2006; 28: 606-619.
18. Muntan CD, Sundine MJ, Rink RD, Acland RD,. Inframammary fold: a histological reappraisal. Plast Reconstr Surg 2000; 105: 549-556.
19. van Straalen WR, Hage JJ, Bloemena E,. The inframammary ligament: myth or reality. Ann Plast Surg 1995; 35: 237-241.
20. Beer GM, Varga Z, Budi S, Seifert B, Meyer VE,. Incidence of the superficial fascia and its relevance in skin-sparing mastectomy. Cancer 2002; 94: 1619-1625.
21. Larson D, Basir Z, Bruce T,. Is oncologic safety compatible with a predictably viable mastectomy skin flap? Plast Reconstr Surg 2011; 127: 27-33.
22. Docquier PL, Paul L, Cartiaux O, Lecouvet F, Dufrane D, Delloye C, et al. Formalin fixation could interfere with the clinical assessment of the tumor-free margin in tumor surgery: magnetic resonance imaging-based study. Oncology 2010; 78: 115-124.
23. Hicken NF,. Mastectomy: a clinical pathologic study demonstrating why most mastectomies result in incomplete removal of the mammary gland. Arch Surg 1940; 40: 6-14.
24. Barton FE Jr, English JM, Kingsley WB, Fietz M,. Glandular excision in total glandular mastectomy and modified radical mastectomy: a comparison. Plast Reconstr Surg 1991; 88: 389-392.
25. Carlson GW, Grossl N, Lewis MM, Temple JR, Styblo TM,. Preservation of the inframammary fold: what are we leaving behind? Plast Reconstr Surg 1996; 98: 447-450.
26. Torresan RZ, dos Santos CC, Okamura H, Alvarenga M,. Evaluation of residual glandular tissue after skin-sparing mastectomies. Ann Surg Oncol 2005; 12: 1037-1044.
27. Cao D, Tsangaris TN, Kouprina N, Wu LS, Balch CM, Vang R, et al. The superficial margin of the skin-sparing mastectomy for breast carcinoma: factors predicting involvement and efficacy of additional margin sampling. Ann Surg Oncol 2008; 15: 1330-1340.
28. Tewari M, Kumar K, Kumar M, Shukla HS,. Residual breast tissue in the skin flaps after Patey mastectomy. Indian J Med Res 2004; 119: 195-197.
29. Goldman LD, Goldwyn RM,. Some anatomical considerations of subcutaneous mastectomy. Plast Reconstr Surg 1973; 51: 501-505.
30. Ho CM, Mak CK, Lau Y, Cheung WY, Chan MC, Hung WK,. Skin involvement in invasive breast carcinoma: safety of skin-sparing mastectomy. Ann Surg Oncol 2003; 10: 102-107.
31. Rusby JE, Kirstein LJ, Brachtel EF, Michaelson JS, Koerner FC, Smith BL,. Nipple-sparing mastectomy: lessons from ex vivo procedures. Breast J 2008; 14: 464-470.
32. Kneubil MC, Lohsiriwat V, Curigliano G, Brollo J, Botteri E, Rotmensz N, et al. Risk of locoregional recurrence in patients with false-negative frozen section or close margins of retroareolar specimen in nipple-sparing mastectomy. Ann Surg Oncol 2012; 19: 4117-4123.
33. Vaughan A, Dietz JR, Aft R, Gillanders WE, Eberlein TJ, Freer P, et al. Scientific Presentation Award. Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate breast reconstruction. Am J Surg 2007; 194: 438-443.
34. Munhoz AM, Montag E, Arruda E, Aldrighi CM, Filassi JR, Piato JR, et al. Immediate reconstruction following breast-conserving surgery: management of the positive surgical margins and influence on secondary reconstruction. Breast 2009; 18: 47-54.
35. Carlson GW, Page A, Johnson E, Nicholson K, Styblo TM, Wood WC,. Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy. J Am Coll Surg 2007; 204: 1074-1078.
36. Sheikh F, Rebecca A, Pockaj B, Wasif N, McCullough A, Casey W, et al. Inadequate margins of excision when undergoing mastectomy for breast cancer: which patients are at risk? Ann Surg Oncol 2011; 18: 952-956.
37. Rowell NP,. Are mastectomy resection margins of clinical relevance? A systematic review. Breast 2009; 19: 14-22.
38. Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, et al. Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 2008; 72: 474-484.
39. Gilliland MD, Larson DL, Copeland EM,. Appropriate timing for breast reconstruction. Plast Reconstr Surg 1983; 72: 335-340.
40. Carlson GW, Styblo TM, Lyles RH, Bostwick J, Murray DR, Staley CA, et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol 2003; 10: 108-112.
41. Carlson GW, Styblo TM, Lyles RH, Jones G, Murray DR, Staley CA, et al. The use of skin sparing mastectomy in the treatment of breast cancer: the Emory experience. Surg Oncol 2003; 12: 265-269.
42. Simmons RM, Fish SK, Gayle L, La Trenta GS, Swistel A, Christos P, et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies. Ann Surg Oncol 1999; 6: 676-681.
43. Garwood ER, Moore D, Ewing C, Hwang ES, Alvarado M, Foster RD, et al. Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients. Ann Surg 2009; 249: 26-32.
44. Lindford AJ, Meretoja TJ, von Smitten KA, Jahkola TA,. Skin-sparing mastectomy and immediate breast reconstruction in the management of locally recurrent breast cancer. Ann Surg Oncol 2010; 17: 1669-1674.
45. Rubio IT, Mirza N, Sahin AA, Whitman G, Kroll SS, Ames FC, et al. Role of specimen radiography in patients treated with skin-sparing mastectomy for ductal carcinoma in situ of the breast. Ann Surg Oncol 2000; 7: 544-548.
46. Yi M, Kronowitz J, Meric-Bernstam F, Feig B, Symmans F, Lucci A, et al. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer 2011; 117: 916-924.
47. Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD, et al. Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Cancer Epidemiol Biomarkers Prev 2009; 18: 2318-2324.
48. Metcalfe KA, Semple JL, Narod SA,. Time to reconsider subcutaneous mastectomy for breast-cancer prevention? Lancet Oncol 2005; 6: 431-434.
49. Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999; 340: 77-84.
50. Heemskerk-Gerritsen BA, Brekelmans CT, Menke-Pluymers MB, van Geel AN, Tilanus-Linthorst MM, Bartels CC, et al. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic. Ann Surg Oncol 2007; 14: 3335-3344.
51. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004; 22: 1055-1062.
52. Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010; 304: 967-975.
53. Evans DG, Baildam AD, Anderson E, Brain A, Shenton A, Vasen HF, et al. Risk reducing mastectomy: outcomes in 10 European centres. J Med Genet 2009; 46: 254-258.
54. Baildam AD,. Best surgical prophylaxis-risk-reducing mastectomy for women at high personal risk of breast cancer. Breast 2006; 15 (Suppl 2): S21-S25.
55. Ghosh K, Hartmann LC,. Current status of prophylactic mastectomy. Oncology (Williston Park) 2002; 16: 1319-1325.
56. Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12: 447-453.
57. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000; 355: 1757-1770.
58. Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S,. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 1995; 13: 2869-2878.
59. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997; 337: 949-955.
60. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999; 353: 1641-1648.
61. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005; 97: 116-126.
62. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al.; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-2106.
63. Lee LJ, Harris JR,. Innovations in radiation therapy (RT) for breast cancer. Breast 2009; 18 (Suppl 3): S103-S111.
64. Kim JH, Tavassoli F, Haffty BG,. Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literature. Cancer J 2006; 12: 92-101.
65. Chadha M, Portenoy J, Boolbol SK, Gillego A, Harrison LB,. Is there a role for postmastectomy radiation therapy in ductal carcinoma in situ? Int J Surg Oncol 2012; 2012: 423520.
66. Godat LN, Horton JK, Shen P, Stewart JH, Wentworth S, Levine EA,. Recurrence after mastectomy for ductal carcinoma in situ. Am Surg 2009; 75: 592-595.
67. Chan LW, Rabban J, Hwang ES, Bevan A, Alvarado M, Ewing C, et al. Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins? Int J Radiat Oncol Biol Phys 2011; 80: 25-30.
68. Kelley L, Silverstein M, Guerra L,. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index. Ann Surg Oncol 2011; 18: 459-462.
69. Fisher B, Dignam J, Bryant J, DeCillis A, Wickerham DL, Wolmark N, et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst 1996; 88: 1529-1542.
70. Fisher B, Dignam J, Mamounas EP, Costantino JP, Wickerham DL, Redmond C, et al. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 1996; 14: 1982-1992.
71. Paige KT, Bostwick J III, Bried JT, Jones G,. A comparison of morbidity from bilateral, unipedicled and unilateral, unipedicled TRAM flap breast reconstructions. Plast Reconstr Surg 1998; 101: 1819-1827.
72. Padubidri AN, Yetman R, Browne E, Lucas A, Papay F, Larive B, et al. Complications of postmastectomy breast reconstructions in smokers, ex-smokers, and nonsmokers. Plast Reconstr Surg 2001; 107: 342-349.
73. Losken A, Styblo TM, Schaefer TG, Carlson GW,. The use of fluorescein dye as a predictor of mastectomy skin flap viability following autologous tissue reconstruction. Ann Plast Surg 2008; 61: 24-29.
74. Alderman AK, Wilkins EG, Kim HM, Lowery JC,. Complications in postmastectomy breast reconstruction: two-year results of the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg 2002; 109: 2265-2274.
75. Khansa I, Colakoglu S, Curtis MS, Yueh JH, Ogunleye A, Tobias AM, et al. Postmastectomy breast reconstruction after previous lumpectomy and radiation therapy: analysis of complications and satisfaction. Ann Plast Surg 2011; 66: 444-451.
76. Gatzoulis MA,. Chest wall and breast. In Gray's Anatomy (40th edn.), Standring S, (ed.). Churchill Livingstone, Elsevier: London, 2008; 915-1038.
77. Palmer JH, Taylor GI,. The vascular territories of the anterior chest wall. Br J Plast Surg 1986; 39: 287-299.
78. Maliniac JW,. Arterial blood supply of the breast: revised anatomic data relating to reconstructive surgery. Arch Surg 1943; 47: 329-343.
79. Rao R, Saint-Cyr M, Ma AM, Bowling M, Hatef DA, Andrews V, et al. Prediction of post-operative necrosis after mastectomy: a pilot study utilizing optical diffusion imaging spectroscopy. World J Surg Oncol 2009; 7: 91.
80. Verheyden CN,. Nipple-sparing total mastectomy of large breasts: the role of tissue expansion. Plast Reconstr Surg 1998; 101: 1494-1500.
81. Newman LA, Kuerer HM, Hunt KK, Kroll SS, Ames FC, Ross MI, et al. Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol 1998; 5: 620-626.
82. Kroll SS, Ames F, Singletary SE, Schusterman MA,. The oncologic risks of skin preservation at mastectomy when combined with immediate reconstruction of the breast. Surg Gynecol Obstet 1991; 172: 17-20.
83. Chun YS, Verma K, Rosen H, Lipsitz SR, Breuing K, Guo L, et al. Use of tumescent mastectomy technique as a risk factor for native breast skin flap necrosis following immediate breast reconstruction. Am J Surg 2011; 201: 160-165.
84. Davies K, Allan L, Roblin P, Ross D, Farhadi J,. Factors affecting post-operative complications following skin sparing mastectomy with immediate breast reconstruction. Breast 2011; 20: 21-25.
85. Fine RE, Vose JG,. Traditional electrosurgery and a low thermal injury dissection device yield different outcomes following bilateral skin-sparing mastectomy: a case report. J Med Case Rep 2011; 5: 212.